Albany, NY (PRWEB) October 21, 2013
Global Testosterone Market 2012 – 2016
Global Testosterone market to grow at a CAGR of 26.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population across the globe. The Global Testosterone market has also been witnessing an increasing number of R&D activities that are focused on developing testosterone replacement therapies. However, the entry of generics could pose a challenge to the growth of this market.
To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/global-testosterone-market-2012-2016
Global Testosterone Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas and the EMEA and APAC regions; it also covers the Global Testosterone market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include AbbVie Inc., Auxilium Pharmaceuticals Inc., Actavis Inc., Eli Lilly & Co., and Endo Health Solutions Inc.
The other vendors mentioned in this report are Actient Pharmaceuticals LLC, Acrux Ltd., Bayer Schering Pharma AG, BioSante Pharmaceuticals Inc., GlaxoSmithKline plc, Kyowa Hakko Kirin Co. Ltd., Pfizer Inc., Teva Pharmaceuticals Industries Ltd., and Trimel BioPharma SRL.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/176833
Key questions answered in this report:
TABLE OF CONTENT